Delivery Order SPE2DB22D3501-SPE2DB24FVW63
Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $37,158.20 and a completion date of May 29, 2024. It is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract, valued at $19,716.00, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $5,390.80 for the HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical product. The award is under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), a single-award IDC worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp is a $5,126.16 delivery order for the product HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 23, 2024. The contract is a firm fixed price arrangement with the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $7,886.40 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a completion date of February 12, 2024. This delivery order is part of an indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order for the medication HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The contract has a ceiling value of $1,684.96 and is a Firm Fixed Price contract with the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside and has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $3,154.56, is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued up to $999,999,999.00 and runs through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp is for the pharmaceutical product HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The $113,657.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of May 22, 2025 and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier of medical and pharmaceutical products to federal agencies,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $14,587.12 and is a Firm Fixed Price Delivery Order with a completion date of June 11, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,590.20 firm-fixed-price contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The award has an ultimate completion date of July 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...